17-May-2024
Globe Newswire (Wed, 15-May 2:21 PM ET)
Beauty Health (SKIN) Receives a Buy from D.A. Davidson
TipRanks (Mon, 13-May 8:25 AM ET)
BeautyHealth Reports First Quarter 2024 Financial Results
Business Wire (Thu, 9-May 4:05 PM ET)
BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024
Business Wire (Fri, 26-Apr 8:00 AM ET)
BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer
Business Wire (Tue, 9-Apr 4:10 PM ET)
BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results
Business Wire (Tue, 12-Mar 4:10 PM ET)
BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer
Business Wire (Tue, 12-Mar 4:05 PM ET)
BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Business Wire (Thu, 29-Feb 4:06 PM ET)
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
Beauty Health Company - Class A trades on the NASDAQ stock market under the symbol SKIN.
As of May 17, 2024, SKIN stock price declined to $2.74 with 878,195 million shares trading.
SKIN has a beta of 0.91, meaning it tends to be less sensitive to market movements. SKIN has a correlation of 0.02 to the broad based SPY ETF.
SKIN has a market cap of $338.75 million. This is considered a Small Cap stock.
Last quarter Beauty Health Company - Class A reported $81 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $870,000 and exceeded earnings estimates by $.04.
In the last 3 years, SKIN stock traded as high as $30.17 and as low as $1.35.
The top ETF exchange traded funds that SKIN belongs to (by Net Assets): VTI, IWM, VXF, VDC, IWO.
SKIN has underperformed the market in the last year with a price return of -73.7% while the SPY ETF gained +29.1%. SKIN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.5% and -18.5%, respectively, while the SPY returned +6.3% and +3.6%, respectively.
SKIN support price is $2.64 and resistance is $2.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SKIN stock will trade within this expected range on the day.